Patent US4124717A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4124717A Expired / Lapsed US ⏱️ 0.0 years remaining

Thiazolyl alkylaminoethylene compounds

Assignee: Smith Kline & French Laboratories Ltd
•
Filing: 1977-05-16
•
Granted: 1978-11-07
•
Expires: 1997-05-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The compounds are ethylene derivatives which are inhibitors of histamine activity, in particular, inhibitors of H-2 histamine receptors. A compound of this invention is 1-nitro-2-methylamino-2-[2-((4-methyl-5-imidazolyl)methylthio)-ethylam ino]ethylene.

Inventors

  • 👤 Graham J. Durant
  • 👤 John C. Emmett
  • 👤 Charon R. Ganellin
  • 👤 Hunter D. Prain

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 23:39
CPC Classifications
C; C07; C07D; C07D275/00; C07D275/02; C07D213/00; C07D213/02; C07D213/04; C07D213/24; C07D213/28; C07D213/32; C07D249/00; C07D249/02; C07D249/08; C07D261/00; C07D261/02; C07D261/06; C07D261/08; C07D285/00; C07D285/01; C07D285/02; C07D285/04; C07D285/08; C07D285/12; C07D285/125; C07D285/135

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 129 words
A compound of the formula: ##STR8## wherein X and Y, which may be the same or different, are hydrogen, nitro, cyano or SO 2 Ar but are not both hydrogen; Het' is thiazole unsubstituted or substituted by lower alkyl, hydroxyl, hydrogen or amino; R is hydrogen, lower alkyl or Het-(CH 2 ) m Z(CH 2 ) n ; Z is sulphur or methylene; each m is 0, 1 or 2 and each n is 2 or 3 provided that each sum of m and n is 3 or 4; Het is an oxazole, isoxazole, triazole, thiazole, isothiazole or thiadiazole ring unsubstituted or substituted by lower alkyl, hydroxyl, halogen or amino; and Ar is phenyl unsubstituted or substituted by halogen or methyl or a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Dependent Claim 129 words
A compound of the formula: ##STR8## wherein X and Y, which may be the same or different, are hydrogen, nitro, cyano or SO 2 Ar but are not both hydrogen; Het' is thiazole unsubstituted or substituted by lower alkyl, hydroxyl, hydrogen or amino; R is hydrogen, lower alkyl or Het-(CH 2 ) m Z(CH 2 ) n ; Z is sulphur or methylene; each m is 0, 1 or 2 and each n is 2 or 3 provided that each sum of m and n is 3 or 4; Het is an oxazole, isoxazole, triazole, thiazole, isothiazole or thiadiazole ring unsubstituted or substituted by lower alkyl, hydroxyl, halogen or amino; and Ar is phenyl unsubstituted or substituted by halogen or methyl or a pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 26 words
A compound of claim 1 wherein X and Y are hydrogen, nitro or cyano, but are not both hydrogen; and R is hydrogen or lower alkyl.
Claim 4
Dependent Claim 27 words
A compound of claim 1 wherein R is methyl or HetCH 2 SCH 2 CH 2 ; Z is sulphur; m is 1 and n is 2.
Claim 5
Dependent Claim 19 words
A compound of claim 1 wherein Het is thiazole or isothiazole and is optionally substituted by methyl or halogen.
Claim 6
Dependent Claim 13 words
A compound of claim 1 wherein X is nitro and Y is hydrogen.
Claim 7
Dependent Claim 9 words
A compound of claim 1, said compound being 1-nitro-2-methylamino-2-[(2-thiazolylmethylthio)ethylamino]ethylene.
Claim 8
Dependent Claim 9 words
A compound of claim 1, said compound being 1-nitro-2,2-bis-[2-(2-thiazolylmethylthio)ethylamino]ethylene.
Claim 9
Dependent Claim 32 words
A pharmaceutical composition to inhibit H-2 histamine receptors, suitable for oral or parenteral administration, comprising a pharmaceutical carrier and in an amount effective to inhibit said receptors a compound of claim 1.
Claim 10
Dependent Claim 32 words
A method of inhibiting H-2 histamine receptors which comprises administering orally or parenterally to an animal in need thereof in an effective amount to inhibit said receptors a compound of claim 1.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-11-06 1982-05-08 1982-11-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-11-06 1986-05-08 1986-11-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-11-06 1990-05-08 1990-11-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag